Details for New Drug Application (NDA): 210207
✉ Email this page to a colleague
NDA 210207 describes CINACALCET HYDROCHLORIDE, which is a drug marketed by Accord Hlthcare, Alkem Labs Ltd, Aurobindo Pharma Ltd, Chartwell Rx, Cipla, Dr Reddys, Hetero Labs Ltd V, Lupin Ltd, Norvium Bioscience, Slate Run Pharma, Stevens J, Strides Pharma, Sun Pharm, and Watson Labs Teva, and is included in fourteen NDAs. It is available from eighteen suppliers. Additional details are available on the CINACALCET HYDROCHLORIDE profile page.
The generic ingredient in CINACALCET HYDROCHLORIDE is cinacalcet hydrochloride. There are twenty-four drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the cinacalcet hydrochloride profile page.
The generic ingredient in CINACALCET HYDROCHLORIDE is cinacalcet hydrochloride. There are twenty-four drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the cinacalcet hydrochloride profile page.
Summary for 210207
| Tradename: | CINACALCET HYDROCHLORIDE |
| Applicant: | Slate Run Pharma |
| Ingredient: | cinacalcet hydrochloride |
| Patents: | 0 |
Pharmacology for NDA: 210207
| Mechanism of Action | Increased Calcium-sensing Receptor Sensitivity |
Medical Subject Heading (MeSH) Categories for 210207
Suppliers and Packaging for NDA: 210207
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| CINACALCET HYDROCHLORIDE | cinacalcet hydrochloride | TABLET;ORAL | 210207 | ANDA | Slate Run Pharmaceuticals | 70436-007 | 70436-007-04 | 30 TABLET, FILM COATED in 1 BOTTLE (70436-007-04) |
| CINACALCET HYDROCHLORIDE | cinacalcet hydrochloride | TABLET;ORAL | 210207 | ANDA | Slate Run Pharmaceuticals | 70436-008 | 70436-008-04 | 30 TABLET, FILM COATED in 1 BOTTLE (70436-008-04) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 30MG BASE | ||||
| Approval Date: | Aug 1, 2018 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 60MG BASE | ||||
| Approval Date: | Aug 1, 2018 | TE: | AB | RLD: | No | ||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 90MG BASE | ||||
| Approval Date: | Aug 1, 2018 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
